Archer-Daniels-Midland Co (ADM)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 adjusted EPS of $0.93 beat Wall Street consensus of ~$0.80*, while GAAP EPS was $0.45; revenue of $21.17B missed consensus of ~$21.81B*, and total segment operating profit fell 10% YoY to $830M .
- Guidance tightened: management now expects full-year 2025 adjusted EPS to be approximately $4.00/share, down from prior $4.00–$4.75 range; Q4 is expected to carry roughly two-thirds of H2 earnings given late-quarter biofuel policy clarity .
- Operational execution improved: Decatur East recommissioned, cost savings initiatives advancing, unscheduled downtime at best levels in 5+ years, and the previously disclosed material weakness in internal controls was remediated .
- Catalyst path: emerging RVO/45Z clarity implies stronger crush and biodiesel margins into Q4; network consolidations and Decatur East ramp should aid Nutrition margin recovery, with segment margin/volume tailwinds to accelerate late-year .
What Went Well and What Went Wrong
What Went Well
- Nutrition delivered sequential improvement and Q2 operating profit rose 5% YoY to $114M; Flavors performance improved and Animal Nutrition margins strengthened, aided by ongoing turnaround actions .
- Decatur East recommissioning supports Specialty Ingredients cost normalization into H2; CEO highlighted best performance in limiting unplanned downtime in more than five years, reflecting execution excellence .
- Corporate finance discipline: leverage at 2.1x, CapEx YTD held to $596M and full-year CapEx range lowered to $1.3–$1.5B from $1.5–$1.7B, with continued dividend return ($495M YTD) .
Management quote: “We achieved our best performance in limiting unscheduled and unplanned downtime in more than five years…[and] are well-positioned to exit 2025 with strong momentum” — Juan Luciano, CEO .
What Went Wrong
- Ag Services & Oilseeds (AS&O) operating profit declined 17% YoY; Crushing was down 75% YoY on lower vegetable oil demand amid biofuel/trade policy uncertainty; Ag Services also saw volume/margin pressure and negative timing impacts .
- Revenue fell 4.9% YoY to $21.17B with gross profit modestly down; GAAP EPS dropped to $0.45 from $0.98 YoY, reflecting margin compression and specified items tied to portfolio optimization and impairments .
- Ethanol margins remained pressured; CFO guided to mid–single-digit decline in ethanol EBITDA margins for 2025 vs 2024 and reiterated softness in starch demand (paper/corrugated) and higher EMEA corn costs .
Financial Results
Consolidated Results – Quarter-over-Quarter
Q2 Year-over-Year
Segment Operating Profit – Trend
Segment Revenues – Q2 2025 vs Q2 2024
Note: Nutrition revenue uplift in Q2 included ~$55M from a contract cancellation in Health & Wellness; the full amount is not included in Nutrition segment operating profit .
KPIs
Guidance Changes
Other guidance notes: AS&O margin improvement expected to primarily benefit Q4 as a portion of Q3 order book was already booked prior to policy clarity .
Earnings Call Themes & Trends
Management Commentary
- “We continued to make progress on operational improvements…advancing our pipeline of portfolio simplification…[and] disciplined capital allocation.” — Juan Luciano, CEO .
- “We expect improved AS&O margins will primarily benefit our fourth quarter results…global soybean crush margins ~$60–$70/MT and canola ~$55–$65/MT.” — Monish Patolawala, CFO .
- “We have successfully remediated the material weakness in internal controls for segment disclosures.” — Monish Patolawala, CFO .
- “Nutrition delivered sequential improvement…Flavors growth and Animal Nutrition margins.” — Monish Patolawala, CFO .
Q&A Highlights
- Earnings cadence: Management guided to roughly one-third of H2 earnings in Q3 and two-thirds in Q4; exit rate for 2025 is expected to set up 2026, but too early to annualize .
- Crush outlook: Biofuel policy clarity favors soybean oil; management sees oil taking ~50% of crush share in supportive scenarios, with margins benefitting across crush/biodiesel complexes if SREs remain benign .
- Nutrition run-rate: Decatur East downtime cost ~$20–25M/quarter; normalization into late 2025/2026 removes ~$100M annual headwind; Flavors strong, Biotics +9% revenue, Animal Nutrition margins improving .
- Internal controls/SEC: Material weakness remediated via enhanced controls/training/testing and auditor oversight; continued focus on transparency and compliance .
- HFCS concern: No changes observed in beverage customer orders/volumes; Carb Solutions managing mix across >22 wet-mill products despite pockets of consumer softness .
Estimates Context
Additional estimates: EPS estimates count = 7*, Revenue estimates count = 6*, Target Price Consensus Mean = $57.6*.
Values retrieved from S&P Global.*
Implications: Mixed print with EPS beat driven by non-GAAP adjustments and segment mix, but top-line and EBITDA below consensus suggest margin compression in AS&O and Carb Solutions; late-quarter policy clarity sets up margin recovery skewed to Q4 .
Key Takeaways for Investors
- EPS beat and tightened full-year guide to ~$4.00/share should focus attention on Q4 execution and policy tailwinds; positioning into Q4 crush cycles is key .
- Expect margin inflection in AS&O in Q4 on RVO/45Z clarity; management provided explicit crush margin ranges, with Q3 constrained by already-booked orders .
- Nutrition recovery is credible with Decatur East ramp and Animal Nutrition margin improvements; Specialty Ingredients cost headwinds should fade, aiding segment profitability into 2026 .
- Ethanol remains a structural headwind (mid single-digit EBITDA margin decline vs 2024); model Carb Solutions conservatively, especially EMEA given corn quality/higher costs .
- Balance sheet flexibility intact with 2.1x leverage and lowered CapEx; continued dividend return supports shareholder yield while cost savings initiatives advance .
- Risk factors: timing/mark-to-market impacts, consumer demand softness in snacks/sweets, and any deviation in final RVO/SRE outcomes could shift margin realization across crush/refining .
- Operational narrative positive: internal controls weakness remediated and unscheduled downtime at multi-year lows; network consolidations (e.g., Bushnell closure) and CO2 conversion partnership (OCOchem) support the self-help/cost and innovation agenda .
Additional Relevant Press Releases (Q3-to-Q2 window)
- ADM announces streamlining of soy protein network, ceasing Bushnell, IL operations; leverages recommissioned Decatur East plant for efficiency gains .
- OCOchem and ADM partner to build CO2 conversion facility at Decatur corn complex, advancing decarbonization pathways tied to Carb Solutions .
- ADM to present at Barclays Consumer Staples Conference (Sept. 3), reinforcing investor engagement and narrative .